BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that management will participate in multiple upcoming investor conferences:
Bicara Therapeutics to Participate in Upcoming Investor Conferences
Seeking Alpha / 7 hours ago 1 Views
Comments